Apex on stronger footing; expands pharmaceutical, consumer products


CEO of Apex Healthcare Bhd, Dr Kee Kirk Chin. - Art Chen/ The Star, 10 June 2014.

PETALING JAYA: Apex Healthcare Bhd’s transformation into a healthcare group from a pharmaceutical-based company has put it on a stronger footing in terms of revenue and earnings.

Chairman and chief executive officer Dr Kee Kirk Chin says Apex’s objective is to be an important regional player by growing the pharmaceutical, consumer products and orthopaedics business and increasing its exports.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , Corporate News , Apex Pharmacy , earnings , 7090 ,

Next In Business News

EcoWorld Malaysia on a roll
Bursa Malaysia ends lower on profit-taking
Rimbunan Sawit suffers RM10mil loss
M-REITs gain appeal on unit price corrections
Real estate market eyes 1H27 turnaround
Ringgit ends lower against the greenback
Banks face Open Finance, KLCI repositioning
Positive outlook for SkyeChip on elevated demand for AI and HPC
Affin Bank unveils new debit card
Aneka Jaringan wins RM26mil building project

Others Also Read